Phase IIMitochondrial Peptide
Compound 61459
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061459
Risk Class
MODERATE
Last Audit
Feb 19, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61459 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase ii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061459 with updates logged 2108-02-19.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61459Mitochondrial Peptide Program 61459
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061459
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61459